AnaptysBio Inc (ANAB)
21.18
+0.88
(+4.31%)
USD |
NASDAQ |
Nov 21, 16:00
21.18
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Market Cap: 644.63M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 618.01M |
| November 19, 2024 | 607.66M |
| November 18, 2024 | 574.49M |
| November 15, 2024 | 578.15M |
| November 14, 2024 | 613.75M |
| November 13, 2024 | 631.40M |
| November 12, 2024 | 654.22M |
| November 11, 2024 | 681.60M |
| November 08, 2024 | 648.44M |
| November 07, 2024 | 653.91M |
| November 06, 2024 | 675.82M |
| November 05, 2024 | 604.92M |
| November 04, 2024 | 606.75M |
| November 01, 2024 | 659.69M |
| October 31, 2024 | 658.17M |
| October 30, 2024 | 674.91M |
| October 29, 2024 | 937.20M |
| October 28, 2024 | 927.77M |
| October 25, 2024 | 974.63M |
| October 24, 2024 | 980.41M |
| October 23, 2024 | 1.057B |
| October 22, 2024 | 1.070B |
| October 21, 2024 | 1.076B |
| October 18, 2024 | 1.064B |
| October 17, 2024 | 1.070B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.056B |
| October 15, 2024 | 1.012B |
| October 14, 2024 | 1.057B |
| October 11, 2024 | 1.011B |
| October 10, 2024 | 973.72M |
| October 09, 2024 | 956.37M |
| October 08, 2024 | 984.37M |
| October 07, 2024 | 1.004B |
| October 04, 2024 | 1.034B |
| October 03, 2024 | 1.066B |
| October 02, 2024 | 1.065B |
| October 01, 2024 | 1.059B |
| September 30, 2024 | 1.019B |
| September 27, 2024 | 962.47M |
| September 26, 2024 | 981.80M |
| September 25, 2024 | 976.66M |
| September 24, 2024 | 1.053B |
| September 23, 2024 | 1.074B |
| September 20, 2024 | 1.162B |
| September 19, 2024 | 1.133B |
| September 18, 2024 | 1.104B |
| September 17, 2024 | 1.132B |
| September 16, 2024 | 1.169B |
| September 13, 2024 | 1.218B |
| September 12, 2024 | 1.157B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
326.14M
Minimum
Nov 22 2019
1.218B
Maximum
Sep 13 2024
651.75M
Average
641.37M
Median
Market Cap Benchmarks
| Eli Lilly and Co | 711.90B |
| Regeneron Pharmaceuticals Inc | 81.80B |
| Ligand Pharmaceuticals Inc | 2.209B |
| Agios Pharmaceuticals Inc | 3.168B |
| ADMA Biologics Inc | 5.034B |
Market Cap Related Metrics
| PS Ratio | 10.16 |
| PEG Ratio | -0.2861 |
| Price to Book Value | 7.641 |
| Price | 21.18 |
| Earnings Yield | -28.70% |
| PEGY Ratio | -0.2861 |